GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fresenius Medical Care FMS · USD

Health Care · US listing · 🇺🇸 United States

Compare

22.95

-1.92%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$22.65bn

FY2016FY2025

Net income

$1.13bn

FY2016FY2025

Free cash flow

$1.96bn

FY2016FY2025

Shareholders' equity

$16.48bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$22.65bn$22.32bn$22.45bn$22.39bn$20.33bn$20.61bn$20.17bn$19.10bn$20.52bn$19.65bn
Gross profit$5.80bn$5.49bn$5.68bn$5.65bn$5.51bn$6.39bn$6.23bn$5.95bn$6.93bn$6.34bn
Research and development$182.3m$211.8m$267.7m$263.9m$254.8m$223.6m$193.9m$154.6m$151.2m$177.8m
Operating income$2.11bn$1.69bn$1.58bn$1.74bn$2.14bn$2.66bn$2.62bn$3.51bn$2.73bn$2.89bn
Net income$1.13bn$620.8m$575.9m$777.2m$1.12bn$1.34bn$1.38bn$2.29bn$1.48bn$1.36bn
Diluted earnings per share1.970.530.650.661.262.291.563.732.412.22

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$35.78bn$38.74bn$39.16bn$41.26bn$39.66bn$36.57bn$38.01bn$30.29bn$27.73bn$29.43bn
Cash and short-term investments$1.85bn$1.55bn$1.80bn$1.69bn$1.89bn$1.43bn$1.34bn$2.61bn$1.15bn$1.12bn
Total liabilities$19.30bn$20.54bn$22.05bn$23.43bn$23.53bn$22.34bn$22.74bn$15.40bn$15.23bn$16.68bn
Debt$12.46bn$12.67bn$13.91bn$15.23bn$15.37bn$14.29bn$15.91bn$8.71bn$8.60bn$9.39bn
Shareholders' equity$16.48bn$16.82bn$15.72bn$16.15bn$14.66bn$14.23bn$13.80bn$13.57bn$11.33bn$11.52bn
Shares outstanding572m1,174m880m1,172m887m586m887m614m614m614m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$2.97bn$2.75bn$3.03bn$2.50bn$2.87bn$4.89bn$2.96bn$2.38bn$2.53bn$2.35bn
Capital spending−$1.01bn−$807.1m−$790.1m−$1.63bn−$1.94bn−$2.41bn−$2.58bn−$2.38bn−$2.06bn−$2.24bn
Free cash flow$1.96bn$1.95bn$2.24bn$872.5m$930.2m$2.48bn$379.7m$2.3m$469.7m$107.5m
Dividends paid−$468.4m−$403.0m−$379.3m−$456.5m−$452.9m−$405.3m−$409.3m−$374.9m−$339.3m−$304.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$5.61bn$5.32bn$5.85bn$5.64bn$5.53bn$4.88bn$5.87bn$4.76bn
Gross profit$1.51bn$1.36bn$1.60bn$1.43bn$1.40bn$1.18bn$1.47bn$1.15bn
Operating income$537.6m$433.4m$633.6m$579.0m$455.2m$381.7m$460.4m$462.7m
Net income$252.0m$135.6m$377.5m$317.1m$260.0m$151.2m$77.2m$213.0m
Diluted earnings per share0.470.250.660.550.450.260.070.18
Cash from operations$992.0m$261.0m$1.12bn$855.0m$894.0m$187.0m$959.0m$1.14bn
Capital spending−$277.0m−$219.0m−$473.0m−$221.0m−$178.0m−$168.0m−$277.0m−$190.0m
Free cash flow$715.0m$42.0m$651.0m$634.0m$716.0m$19.0m$682.0m$946.0m
Total assets$36.12bn$36.32bn$35.78bn$35.65bn$36.11bn$37.78bn$38.74bn$37.52bn
Cash and short-term investments$1.67bn$1.87bn$1.85bn$1.45bn$2.53bn$1.24bn$1.55bn$1.58bn
Debt$9.41bn$9.38bn$12.46bn$12.09bn$12.72bn$12.49bn$12.67bn$12.93bn
Shareholders' equity$14.49bn$15.28bn$16.48bn$14.94bn$15.32bn$16.59bn$16.82bn$15.72bn

Financial ratios

Data as of 3 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin25.6%24.6%25.3%25.2%27.1%31.0%
Operating margin9.3%7.6%7.0%7.8%10.5%12.9%
Net margin5.0%2.8%2.6%3.5%5.5%6.5%
Return on equity6.8%3.7%3.7%4.8%7.6%9.4%
Return on assets3.2%1.6%1.5%1.9%2.8%3.7%
Free cash flow yield27.2%11.8%16.9%13.7%21.1%48.5%
Revenue growth1.5%-0.6%0.3%10.1%-1.3%2.2%
Earnings growth81.9%7.8%-25.9%-30.5%-16.8%-2.9%
Current ratio1.26x1.40x1.42x1.27x1.10x1.18x
Debt to equity0.55x0.51x0.63x0.66x0.73x0.69x
Equity ratio46.1%43.4%40.1%39.1%37.0%38.9%
Interest coverage4.75x3.60x3.22x4.20x5.24x5.62x
R&D as a share of sales0.8%0.9%1.2%1.2%1.3%1.1%
Buybacks as a share of market value51.3%-33.4%24.9%-32.1%-51.5%34.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.4%1.9%2.5%
Operating income6.5%-4.5%-1.5%
Net income13.3%-3.4%0.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin25.1%25.2%26.4%28.8%
Operating margin8.5%7.9%9.1%11.5%
Net margin3.9%3.5%4.3%5.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings12.142.831.824.625.818.123.68.721.819.0
Price to sales0.61.20.80.91.41.21.61.01.61.3

Market value over time

30 Nov 2016 to 2 Oct 2026, in USD

$23.88bn$12.00bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return2%12%32%-48%-27%15%9%-36%25%1%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.